FindTrial
Sign In

A medical records based retrospective analysis of incidence and risk factors of venous thromboembolism after transurethral resection of prostate

Retrospective analysis of incidence and risk factors of venous thromboembolism after transurethral resection of prostate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045455
Enrollment
Unknown
Registered
2021-04-15
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

Patients without VTE/PE after TURP:Nil
Patients with VTE/PE after TURP:Nil

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Jan.2017-Dec.2020 BPH patients in Xiangya Hospital who are eligible to the TURP surgery.

Exclusion criteria

Exclusion criteria: 1. Active malignant disease; 2. Previous prostate surgery or urinary reconstructive surgery; 3. Postoperative disease examination was actually prostate CA; 4. Inability to tolerate TURP surgery (such as poor cardiopulmonary function and poor coagulation function); 5. The presence of VTE in lower extremity vascular color ultrasound was perfected preoperatively.

Design outcomes

Primary

MeasureTime frame
Lower extremity vascular ultrasound;—

Secondary

MeasureTime frame
Swelling or pain in the lower limbs;Chest pain, chest tightness and other chest symptoms;Pulmonary artery CTA;—

Countries

China

Contacts

Public ContactTang Zhengyan

Xiangya Hospital, Central South University

xytzyan@163.com+86 13507318268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026